Changeflow GovPing Healthcare Adjustable Interatrial Devices Control Heart Bl...
Routine Notice Added Final

Adjustable Interatrial Devices Control Heart Blood Flow

Email

Summary

The USPTO has published a patent application for an adjustable interatrial device designed to control blood flow between the atria of a patient's heart. The application, filed by Brian Fahey and William Jason Fox, details a device that can be adjusted to open or close blood flow based on sensor readings.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

This document is a patent application (US20260083562A1) filed with the USPTO for an adjustable interatrial device. The invention aims to control blood flow between the right and left atria of a heart, with the device's lumen being adjustable between an open and closed state, potentially based on pressure sensor data. The application lists Brian Fahey and William Jason Fox as inventors.

This patent application does not impose any immediate regulatory obligations or deadlines on regulated entities. It represents a new invention in the field of medical devices, specifically cardiovascular implants. Companies in the medical device sector, particularly those developing cardiac closure or flow control devices, may find this patent application of interest for competitive intelligence or potential licensing opportunities.

Archived snapshot

Mar 27, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

ADJUSTABLE INTERATRIAL DEVICES

Application US20260083562A1 Kind: A1 Mar 26, 2026

Inventors

Brian Fahey, William Jason Fox

Abstract

Closure devices that selectively control blood flow between the right atrium and the left atrium of a heart of a patient. The control of blood flow can be based on detected values from a pressure sensor. The closure devices can include a body configured to engage native tissue when the device is deployed across the septal wall. In a first state at least a portion of (an inner surface of) a lumen is closed, preventing blood flow through the closure device. In a second state, the lumen is open to enable blood flow from the left atrium to the right atrium. A closure element can be selectively adjusted to control the flow of blood through the lumen. A volume of an expandable chamber can be increased or decreased to place the closure device into the first state or the second state.

CPC Classifications

A61F 2/2476 A61B 5/02158 A61B 5/686 A61B 5/6869 A61B 2562/0247 A61F 2210/0033 A61F 2220/0008 A61F 2250/0013

Filing Date

2025-11-27

Application No.

19403121

View original document →

Named provisions

Abstract

Get daily alerts for USPTO Patent Applications - Prosthetics (A61F)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260083562A1

Who this affects

Applies to
Patients Healthcare providers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Medical Device Development
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Product Development
Topics
Medical Devices Pharmaceuticals

Get alerts for this source

We'll email you when USPTO Patent Applications - Prosthetics (A61F) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!